271 related articles for article (PubMed ID: 17562647)
1. Modelling of bioassay data from a Pu wound treated by repeated DTPA perfusions: biokinetics and dosimetric approaches.
Fritsch P; Grappin L; Guillermin AM; Fottorino R; Ruffin M; Mièle A
Radiat Prot Dosimetry; 2007; 127(1-4):120-4. PubMed ID: 17562647
[TBL] [Abstract][Full Text] [Related]
2. USTUR whole body case 0262: 33-y follow-up of PuO2 in a skin wound and associated axillary node.
James AC; Sasser LB; Stuit DB; Wood TG; Glover SE; Lynch TP; Dagle GE
Radiat Prot Dosimetry; 2007; 127(1-4):114-9. PubMed ID: 18227076
[TBL] [Abstract][Full Text] [Related]
3. Ustur whole body case 0269: demonstrating effectiveness of i.v. CA-DTPA for Pu.
James AC; Sasser LB; Stuit DB; Glover SE; Carbaugh EH
Radiat Prot Dosimetry; 2007; 127(1-4):449-55. PubMed ID: 18227077
[TBL] [Abstract][Full Text] [Related]
4. Treatment of human contamination with plutonium and americium: would orally administered Ca- or Zn-DTPA be effective?
Taylor DM; Hodgson SA; Stradling N
Radiat Prot Dosimetry; 2007; 127(1-4):469-71. PubMed ID: 17556346
[TBL] [Abstract][Full Text] [Related]
5. The CONRAD approach to biokinetic modeling of DTPA decorporation therapy.
Breustedt B; Blanchardon E; Bérard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
Health Phys; 2010 Oct; 99(4):547-52. PubMed ID: 20838097
[TBL] [Abstract][Full Text] [Related]
6. Biokinetic modelling of DTPA decorporation therapy: the CONRAD approach.
Breustedt B; Blanchardon E; Berard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
Radiat Prot Dosimetry; 2009 Feb; 134(1):38-48. PubMed ID: 19351653
[TBL] [Abstract][Full Text] [Related]
7. The NCRP wound model: development and application.
Guilmette RA; Durbin PW; Toohey RE; Bertelli L
Radiat Prot Dosimetry; 2007; 127(1-4):103-7. PubMed ID: 17766262
[TBL] [Abstract][Full Text] [Related]
8. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
[TBL] [Abstract][Full Text] [Related]
9. Plutonium-DTPA Model Application with USTUR Case 0269.
Konzen K; Brey R; Miller S
Health Phys; 2016 Jan; 110(1):59-65. PubMed ID: 26606066
[TBL] [Abstract][Full Text] [Related]
10. Three plutonium chelation cases at Los Alamos National Laboratory.
Bertelli L; Waters TL; Miller G; Gadd MS; Eaton MC; Guilmette RA
Health Phys; 2010 Oct; 99(4):532-8. PubMed ID: 20838095
[TBL] [Abstract][Full Text] [Related]
11. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms.
Sérandour AL; Tsapis N; Gervelas C; Grillon G; Fréchou M; Deverre JR; Bénech H; Fattal E; Fritsch P; Poncy JL
Radiat Prot Dosimetry; 2007; 127(1-4):472-6. PubMed ID: 17562654
[TBL] [Abstract][Full Text] [Related]
12. A case of wound intake of plutonium isotopes and 241Am in a human: application and improvement of the NCRP wound model.
Schadilov AE; Belosokhov MV; Levina ES
Health Phys; 2010 Oct; 99(4):560-7. PubMed ID: 20838099
[TBL] [Abstract][Full Text] [Related]
13. Prediction of monitoring data for 239Pu accidentally injected via wound site based on the proposed NCRP wound model.
Ishigure N
Radiat Prot Dosimetry; 2007; 127(1-4):108-13. PubMed ID: 17561522
[TBL] [Abstract][Full Text] [Related]
14. Effect of calcium trisodium DTPA in rats with puncture wound contaminated by 90Y-chloride.
Watanabe N; Tanada S; Sasaki Y
Radiat Prot Dosimetry; 2005; 114(4):509-13. PubMed ID: 15899907
[TBL] [Abstract][Full Text] [Related]
15. Current and future radionuclide speciation studies in biological media.
Ansoborlo E; Bion L; Doizi D; Moulin C; Lourenco V; Madic C; Cote G; Van der Lee J; Moulin V
Radiat Prot Dosimetry; 2007; 127(1-4):97-102. PubMed ID: 17578878
[TBL] [Abstract][Full Text] [Related]
16. Twenty-four years of follow-up for a Hanford plutonium wound case.
Carbaugh EH; Lynch TP; Antonio CL; Medina-Del Valle F
Health Phys; 2010 Oct; 99(4):483-94. PubMed ID: 20838089
[TBL] [Abstract][Full Text] [Related]
17. Practical action levels for chelation therapy in plutonium inhalation using nose swab.
Kurihara O; Takada C; Takasaki K; Ito K; Momose T; Miyabe K
Radiat Prot Dosimetry; 2007; 127(1-4):411-4. PubMed ID: 17567761
[TBL] [Abstract][Full Text] [Related]
18. Enhanced decorporation of plutonium by DTPA encapsulated in small PEG-coated liposomes.
Phan G; Le Gall B; Grillon G; Rouit E; Fouillit M; Benech H; Fattal E; Deverre JR
Biochimie; 2006 Nov; 88(11):1843-9. PubMed ID: 16860919
[TBL] [Abstract][Full Text] [Related]
19. MADOR: a new tool to calculate decrease of effective doses in human after DTPA therapy.
Fritsch P; Grémy O; Hurtgen C; Bérard P; Grappin L; Poncy JL
Radiat Prot Dosimetry; 2011 Mar; 144(1-4):371-5. PubMed ID: 21131659
[TBL] [Abstract][Full Text] [Related]
20. Treatment of actinide exposures: a review of Ca-DTPA injections inside CEA-COGEMA plants.
Grappin L; Berard P; Menetrier F; Carbone L; Courtay C; Castagnet X; Le Goff JP; Neron MO; Piechowski J
Radiat Prot Dosimetry; 2007; 127(1-4):435-9. PubMed ID: 17940101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
